DETAILED ACTION
1 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 5/26/2026 has been entered.
2 The rejection of claims 19-38 under 35 U.S.C. 103 as being unpatentable over Lim et al. (US’ 519 A1) in view of Wang Jeffrey (US’ 832 A1) is maintained for the reasons set forth in the previous Office action mailed on April 29,2025,
3 The rejection of claims 19-38 under 35 U.S.C. 103 as being unpatentable over Nicou et al. (US’ 851 A1) in view of Wang Jeffrey (US’ 832 A1) is withdrawn because of the comparative data presented in the claimed specification, pages 45-47, Example 1, Table 3, that shows the criticality of 2-amino-5-ethylphenol in the claimed invention A over the comparative composition C that does not comprise 2-amino-5-ethylphenol.
Response to the applicant’s Arguments
4 Applicant's arguments filed on 05/26/2026 have been fully considered but they are not persuasive.
With respect to applicant’s argument based on the unexpected results of the claimed invention, the examiner would like to mention that, the examples in Table A and Table C are not recited in the claimed specification and therefore, are of no probative value in determining patentability of the claims.
Further, claims 19, 37 and 38 as independent claims, do not recite or disclose the percentage amounts of the claimed ingredients that recite in Table A provided by applicant as a comparative data to overcome the rejection.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to EISA B ELHILO whose telephone number is (571)272-1315. The examiner can normally be reached Monday-Friday, 7:00 AM to 3:30 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at (571)272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/EISA B ELHILO/Primary Examiner, Art Unit 1761
Prosecution Insights